BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26056041)

  • 1. ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells.
    Liu X; Yu X; Xie J; Zhan M; Yu Z; Xie L; Zeng H; Zhang F; Chen G; Yi X; Zheng J
    Oncotarget; 2015 Aug; 6(25):21004-15. PubMed ID: 26056041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis.
    Carbone C; Piro G; Fassan M; Tamburrino A; Mina MM; Zanotto M; Chiao PJ; Bassi C; Scarpa A; Tortora G; Melisi D
    Oncotarget; 2015 May; 6(15):13822-34. PubMed ID: 25360865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune inhibitory receptor LILRB2 is critical for the endometrial cancer progression.
    Shao H; Ma L; Jin F; Zhou Y; Tao M; Teng Y
    Biochem Biophys Res Commun; 2018 Nov; 506(1):243-250. PubMed ID: 30343889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-expression of immunoglobulin-like transcript 4 and angiopoietin-like proteins in human non-small cell lung cancer.
    Wang L; Geng T; Guo X; Liu J; Zhang P; Yang D; Li J; Yu S; Sun Y
    Mol Med Rep; 2015 Apr; 11(4):2789-96. PubMed ID: 25482926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A motif in LILRB2 critical for Angptl2 binding and activation.
    Deng M; Lu Z; Zheng J; Wan X; Chen X; Hirayasu K; Sun H; Lam Y; Chen L; Wang Q; Song C; Huang N; Gao GF; Jiang Y; Arase H; Zhang CC
    Blood; 2014 Aug; 124(6):924-35. PubMed ID: 24899623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient expansion of mouse hematopoietic stem cells ex vivo by membrane anchored Angptl2.
    Yang J; Shen G; Cao J; Zhang J; Gu Y; Zhang X; Jiang X; Luo M; Lu Z
    Biochem Biophys Res Commun; 2022 Aug; 617(Pt 1):42-47. PubMed ID: 35675737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paired immunoglobulin-like receptor B regulates platelet activation.
    Fan X; Shi P; Dai J; Lu Y; Chen X; Liu X; Zhang K; Wu X; Sun Y; Wang K; Zhu L; Zhang CC; Zhang J; Chen GQ; Zheng J; Liu J
    Blood; 2014 Oct; 124(15):2421-30. PubMed ID: 25075127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ILT3 promotes tumor cell motility and angiogenesis in non-small cell lung cancer.
    Li J; Gao A; Zhang F; Wang S; Wang J; Wang J; Han S; Yang Z; Chen X; Fang Y; Jiang G; Sun Y
    Cancer Lett; 2021 Mar; 501():263-276. PubMed ID: 33152402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin-like transcript 4 promotes tumor progression and metastasis and up-regulates VEGF-C expression via ERK signaling pathway in non-small cell lung cancer.
    Zhang P; Guo X; Li J; Yu S; Wang L; Jiang G; Yang D; Wei Z; Zhang N; Liu J; Sun Y
    Oncotarget; 2015 May; 6(15):13550-63. PubMed ID: 25948790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANGPTL2 knockdown induces autophagy to relieve alveolar macrophage pyroptosis by reducing LILRB2-mediated inhibition of TREM2.
    Yang F; Chen M; Liu Y; Hu Y; Chen Y; Yu Y; Deng L
    J Cell Mol Med; 2024 May; 28(10):e18280. PubMed ID: 38758159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of ANGPTL2 and LILRB2 as predictive and therapeutic biomarkers for metastasis and prognosis in colorectal cancer.
    He J; Xu J; Yu X; Zhu H; Zeng Y; Fan D; Yi X
    Int J Clin Exp Pathol; 2018; 11(5):2281-2294. PubMed ID: 31938340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
    Wong JC; Bathina M; Fiscus RR
    J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LILRB2-containing small extracellular vesicles from glioblastoma promote tumor progression by promoting the formation and expansion of myeloid-derived suppressor cells.
    Wu P; Guo Y; Xiao L; Yuan J; Tang C; Dong J; Qian Z
    Cancer Immunol Immunother; 2023 Jul; 72(7):2179-2193. PubMed ID: 36853330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANGPTL2 Induces Synovial Inflammation via LILRB2.
    Nishiyama S; Hirose N; Yanoshita M; Takano M; Kubo N; Yamauchi Y; Onishi A; Ito S; Sakata S; Kita D; Asakawa-Tanne Y; Tanimoto K
    Inflammation; 2021 Jun; 44(3):1108-1118. PubMed ID: 33538932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CAMKs support development of acute myeloid leukemia.
    Kang X; Cui C; Wang C; Wu G; Chen H; Lu Z; Chen X; Wang L; Huang J; Geng H; Zhao M; Chen Z; Müschen M; Wang HY; Zhang CC
    J Hematol Oncol; 2018 Feb; 11(1):30. PubMed ID: 29482582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
    Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
    Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ICAM-3 enhances the migratory and invasive potential of human non-small cell lung cancer cells by inducing MMP-2 and MMP-9 via Akt and CREB.
    Park JK; Park SH; So K; Bae IH; Yoo YD; Um HD
    Int J Oncol; 2010 Jan; 36(1):181-92. PubMed ID: 19956847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiopoietin-Like Protein 2 Acts as a Novel Biomarker for Diagnosis and Prognosis in Patients with Esophageal Cancer.
    Ide S; Toiyama Y; Shimura T; Kawamura M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Mohri Y; Kusunoki M
    Ann Surg Oncol; 2015 Aug; 22(8):2585-92. PubMed ID: 25564164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ILT4 drives B7-H3 expression via PI3K/AKT/mTOR signalling and ILT4/B7-H3 co-expression correlates with poor prognosis in non-small cell lung cancer.
    Zhang P; Yu S; Li H; Liu C; Li J; Lin W; Gao A; Wang L; Gao W; Sun Y
    FEBS Lett; 2015 Aug; 589(17):2248-56. PubMed ID: 26149216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity.
    Chen HM; van der Touw W; Wang YS; Kang K; Mai S; Zhang J; Alsina-Beauchamp D; Duty JA; Mungamuri SK; Zhang B; Moran T; Flavell R; Aaronson S; Hu HM; Arase H; Ramanathan S; Flores R; Pan PY; Chen SH
    J Clin Invest; 2018 Dec; 128(12):5647-5662. PubMed ID: 30352428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.